Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma
Clinical trial NCT03143049 · UNKNOWN
Trial details
- NCT number
- NCT03143049
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2018-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.